Shenzhen Xinpeng Biotech Co., Ltd.

Company Description

We hold a strong company profile owing to 6 Years of export history and the most satisfied consumer base we achieved through our finest quality filgrastim,Erythropoietin,Octreotide Acetate in the industry. Shenzhen Xinpeng Biotech Co., Ltd. was first introduced in Shenzhen, Guangdong, China, with initial capital estimating US$5 Million.Since our inception back in 2014 as Manufacturer and Retailer of Erythropoietin Injection we have been constantly working on our product line, now holding Australia,Chile,Spain,Nigeria,Thailand export market share. We have developed our manufacturing facility in to one technologically advanced production entity delivering finely finished products promising years of service. Constant quality maintenance and speedy delivery led us to annual revenue worth Above US$100 Million. We have scored consumer reliability as well being a Private Limited operating under Have Own Export License. Our export ratio value has now reached Above US$100 Million, thanks to finely developed Erythropoietin Injection being exported across different regions.